Find information on thousands of medical conditions and prescription drugs.

Varicella Zoster

The varicella-zoster virus (VZV), also known as human herpesvirus 3 (HHV-3), is one of the eight herpesviruses known to affect humans (and other vertebrates). Primary VZV infection results in chickenpox (varicella), which may rarely result in complications including VZV encephalitis. Even when clinical symptoms of varicella have resolved, VZV remains dormant in the nervous system of the host in the trigeminal and dorsal root ganglia. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
Vaccinophobia
VACTERL association
Vaginismus
Van der Woude syndrome
Van Goethem syndrome
Varicella Zoster
Variegate porphyria
Vasculitis
Vasovagal syncope
VATER association
Velocardiofacial syndrome
Ventricular septal defect
Vipoma
Viral hemorrhagic fever
Vitamin B12 Deficiency
Vitiligo
VLCAD deficiency
Von Gierke disease
Von Hippel-Lindau disease
Von Recklinghausen disease
Von Willebrand disease
Vulvodynia
W
X
Y
Z
Medicines

In about 10-20% of cases, VZV reactivates later in life to produce herpes zoster (shingles) and its associated sequelae including: post-herpetic neuralgia, zoster multiplex, myelitis, herpes ophthalmicus, or zoster sine herpete.

VZV is closely related to the herpes simplex viruses (HSV), sharing much genome homology. The known envelope glycoproteins (gB, gC, gE, gH, gI, gK, gL) correspond with those in HSV, however there is not equivalent of HSV gD. VZV virons are spherical and 150-200 nm in diameter. Its lipid envelope encloses the nucleocapsid of 162 capsomeres arranged in a hexagonal form. Its DNA is a single linear, double strand molecule, 125,000 nt long.

The virus is very susceptible to disinfectants, notably sodium hypochlorite. Within the body it can be treated by a number of drugs and therapeutic agents including aciclovir, zoster immunoglobulin (ZIG), and vidarabine.

A live attenuated VZV Oka/Merck strain vaccine is available and is marketed under the trade name Varivax. It was developed by Merck, Sharp & Dohme in the 1980s from the Oka strain virus isolated and attenuated by Michiaki Takahashi and colleagues in the 1970s. It was submitted to the U.S. Food and Drugs Administration for approval in 1990 and was approved in 1995. Since then, it has been added to the recommended vaccination schedules for children in Australia, the United States, and many other countries, causing controversy because it is only expected to be effective for about twenty years, leaving adults vulnerable to the most dangerous forms of infection by this virus, whereas getting normal chickenpox as a child typically leaves them immune for life.

Read more at Wikipedia.org


[List your site here Free!]



New variant of varicella-zoster virus - Dispatches
In 1998, a varicella-zoster virus glycoprotein E (gE) mutant virus (VZV-MSP) was isolated from a child with chickenpox. VZV-MSP, representing a second ...
Varicella-Zoster Virus Infection: Recent Advances
Varicella-zoster virus remains latent in the body and can cause several clinical syndromes. Antiviral agents provide a way to treat adults with herpes ...
Varicella zoster vaccination: an update
Varicella is a highly contagious condition manifested by fever and a three- to five-day centripetal rash. Vasquez reviewed the current state of varicella ...
PREVALENCE OF IgG VARICELLA ZOSTER VIRUS ANTIBODIES IN THE KUIKURO AND KAIABI INDIGENOUS COMMUNITIES IN XINGU NATIONAL PARK, BRAZIL, BEFORE VARICELLA VACCINATION
SUMMARY The purpose of the study was to estimate the prevalence of IgG antibodies against varicella zoster virus (VZV) in the two most populated indigenous ...
A SIMPLE AND CHEAPER IN HOUSE VARICELLA ZOSTER VIRUS ANTIBODY INDIRECT ELISA
SUMMARY We have developed a cheaper an simple in house indirect ELISA that uses the live attenuated VZV vaccine as a coating antigen. The alternative ELISA had an agreement of 94% when compared with
Effectiveness of varicella vaccine in children
Administration of varicella vaccine is recommended for children 12 to 18 months of age and for older children who have not already had chickenpox. However, ...
Evaluation and treatment of patients with herpes zoster - Tips from Other Journals
More than 90 percent of U.S. adults have serologic evidence of varicella-zoster virus infection and are at risk for subsequent reactivation, in the form of herpes zoster (shingles). The reactivatio
Varicella-zoster virus infections in pregnancy
Varicella-Zoster Virus Infections in Pregnancy Varicella-zoster virus can cause a distinct congenital syndrome, a potentially fatal neonatal infection ...

Home Contact Resources Exchange Links ebay